Australia, Nov. 25 -- CSL Behring Gmbh, owns the trademark (2564826) for 'RESPIMUNE' till March 17, 2035.
Status: protected:
Registered/protected
Classes: 41 [Provision of educational services relating to health; publication of the results of clinical trials; education services relating to therapeutic treatments.], 42 [Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about the results of clinical trials for pharmaceutical products; providing scientific information in the field of medical disorders and their treatment.] and 44 [Provision of pharmaceutical information; provision of medical information.]
Type of Mark: Word
Date of Acceptance: Sept. 17
Registration Advertised: Nov. 24
For further details contact Frank Schone de la Nuez.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2564826.
Disclaimer: Curated by HT Syndication.
